InMed Pharmaceuticals Inc. - Common Shares, no par value (INM)

CUSIP: 457637601

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Shares, no par value
Shares outstanding
804,525
Total 13F shares
26,865
Share change
+11,130
Total reported value
$18,551
Price per share
$0.69
Number of holders
8
Value change
+$7,235
Number of buys
5
Number of sells
2

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 457637601?
CUSIP 457637601 identifies INM - InMed Pharmaceuticals Inc. - Common Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of INM - InMed Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
1.7%
13,672
 $12,578 — 30 Jun 2023
13F
Bruce Colwill
3/4/5
CFO —
class O/S missing
11,515
 $10,294 — 24 Jan 2022
3/4/5
BANK OF AMERICA CORP /DE/
13F
Company
0.23%
1,834
 $1,698 — 30 Jun 2023
13F
TD Waterhouse Canada Inc.
13F
Company
0.01%
85
 $103 — 30 Jun 2023
13F
BlackRock Finance, Inc.
13F
Company
0.01%
50
 $46 — 30 Jun 2023
13F
OSAIC HOLDINGS, INC.
13F
Company
0.01%
42
 $35 — 30 Jun 2023
13F
AllSquare Wealth Management LLC
13F
Company
0%
21
 $26 — 30 Jun 2023
13F
Federation Des Caisses Desjardins du Quebec
13F
Individual
0%
19
 $18 — 30 Jun 2023
13F
NATIONAL BANK OF CANADA /FI/
13F
Company
0%
12
 $11 — 30 Jun 2023
13F
Catherine Sazdanoff
3/4/5
Director —
class O/S missing
29,091
 — — 29 Dec 2021
3/4/5
Adam D. Cutler
3/4/5
Director —
class O/S missing
16,122
 — — 24 Jan 2022
3/4/5
Mr. William J. Garner
3/4/5
Director —
class O/S missing
16,122
 — — 24 Jan 2022
3/4/5
Ms. Sarah Li
3/4/5
VP Accounting & Controller —
class O/S missing
4,002
 — — 16 Dec 2022
3/4/5

Institutional Holders of InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) as of Q3 2023

As of 30 Sep 2023, InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,865 shares. The largest 8 holders included SUSQUEHANNA INTERNATIONAL GROUP, LLP, TD Waterhouse Canada Inc., UBS Group AG, OSAIC HOLDINGS, INC., AllSquare Wealth Management LLC, NATIONAL BANK OF CANADA /FI/, Federation des caisses Desjardins du Quebec, and GABLES CAPITAL MANAGEMENT INC.. This page lists 8 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders
7
Q3 2023 holders
8
Holder diff
1
Investor Q2 2023 Shares Q3 2023 Shares Share Diff Share Chg % Q2 2023 Value $ Q3 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored